Genmab A/S (GMAB.CO)

DKK 1486.5

(4.13%)

Annual Income Statements

(In DKK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 16.47 Billion 14.59 Billion 8.48 Billion 10.11 Billion 5.36 Billion 3.02 Billion
Cost of Revenue 226 Million - - - - -
Gross Profit 16.24 Billion 14.59 Billion 8.48 Billion 10.11 Billion 5.36 Billion 3.02 Billion
Operating Expenses 10.92 Billion 8.23 Billion 5.46 Billion 3.79 Billion 2.72 Billion 1.64 Billion
Selling, General and Administrative Expenses 3.29 Billion 2.67 Billion 1.28 Billion 661 Million 342 Million 213.69 Million
Research and Development Expenses 7.63 Billion 5.56 Billion 4.18 Billion 3.13 Billion 2.38 Billion 1.43 Billion
Other Expenses - - - - - -
Cost and Expenses 11.15 Billion 8.23 Billion 5.46 Billion 3.79 Billion 2.72 Billion 1.64 Billion
Operating Income 5.32 Billion 6.35 Billion 3.01 Billion 6.31 Billion 2.63 Billion 1.38 Billion
Interest Expense 27 Million 21 Million 13 Million 10 Million 7 Million 417 Thousand
Income Tax Expense 1.28 Billion 1.51 Billion 975 Million 1.14 Billion 693 Million 139.83 Million
Earnings before Tax 5.63 Billion 7.03 Billion 3.98 Billion 5.9 Billion 2.85 Billion 1.61 Billion
Net Income 4.35 Billion 5.45 Billion 2.95 Billion 4.75 Billion 2.16 Billion 1.47 Billion
Earnings Per Share Basic 66.64 83.38 46.00 73.00 34.40 24.03
Earnings Per Share Diluted 66.02 82.59 45.54 72.22 34.04 23.73
Weighted Average Shares Outstanding 65.3 Million 65.38 Million 65.39 Million 65.17 Million 62.96 Million 61.26 Million
Weighted Average Shares Outstanding (Diluted) 65.91 Million 66 Million 66.04 Million 65.88 Million 63.63 Million 62.04 Million
Gross Margin 0.99 1.00 1.00 1.00 1.00 1.00
EBIT Margin 0.34 0.48 0.41 0.67 0.54 0.56
Profit Margin 0.26 0.37 0.35 0.47 0.40 0.49
EBITDA 5.56 Billion 7.25 Billion 4.24 Billion 6.16 Billion 2.77 Billion 1.69 Billion
Earnings Before Tax Margin 0.32 0.44 0.36 0.62 0.49 0.46

Income Statement Charts